Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials, which are expected to deliver the same therapeutic effect as the branded drug product Acetadote Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials of Cumberland Pharmaceuticals Inc. Acetylcysteine, a widely used therapeutic agent, is employed to treat acetaminophen overdose and as a mucolytic agent in managing respiratory conditions. Glenmark acquired the ANDA fo...